SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-036587
Filing Date
2024-02-14
Accepted
2024-02-14 17:15:18
Documents
17
Period of Report
2024-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d756637d8k.htm   iXBRL 8-K 29750
2 EX-1.1 d756637dex11.htm EX-1.1 186848
3 EX-5.1 d756637dex51.htm EX-5.1 11114
7 GRAPHIC g756637g0213224659254.jpg GRAPHIC 3608
  Complete submission text file 0001193125-24-036587.txt   416402

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA maia-20240214.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20240214_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20240214_pre.xml EX-101.PRE 11707
18 EXTRACTED XBRL INSTANCE DOCUMENT d756637d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 24640534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)